Amplicorepharma
1 known investors
Amplicore develops injectable regenerative therapeutics for degenerative musculoskeletal disorders, including joint osteoarthritis, cartilage damage, degenerative disc disease, and acute meniscus tears. The products aim to address the underlying causes of joint conditions while relieving pain through minimally invasive delivery.
BiotechHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does Amplicorepharma do?
- Amplicore develops injectable regenerative therapeutics for degenerative musculoskeletal disorders, including joint osteoarthritis, cartilage damage, degenerative disc disease, and acute meniscus tears. The products aim to address the underlying causes of joint conditions while relieving pain through minimally invasive delivery.
- Who are Amplicorepharma's investors?
- Amplicorepharma's investors include Berkeley Catalyst.